An intensive model of care for hepatitis C virus screening and treatment with direct‐acting antivirals in people who inject drugs in Nairobi, Kenya: a model‐based cost‐effectiveness analysis-Reference-Cited by-同舟云学术

An intensive model of care for hepatitis C virus screening and treatment with direct‐acting antivirals in people who inject drugs in Nairobi, Kenya: a model‐based cost‐effectiveness analysis

Published:2021-07-28 Issue:2 Volume:117 Page:411-424
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

Mafirakureva Nyashadzaishe¹^ORCID,Stone Jack¹,Fraser Hannah¹^ORCID,Nzomukunda Yvonne²,Maina Aron²,Thiong'o Angela W.²,Kizito Kibango Walter²,Mucara Esther W. K.³,González Diaz C. Inés³,Musyoki Helgar⁴,Mundia Bernard⁵,Cherutich Peter⁶,Nyakowa Mercy⁶,Lizcano John⁷,Chhun Nok⁷,Kurth Ann⁷,Akiyama Matthew J.⁸,Waruiru Wanjiru⁹,Bhattacharjee Parinita¹⁰,Cleland Charles¹¹,Donchuk Dmytro¹²,Luhmann Niklas¹³,Loarec Anne¹⁴,Maman David¹⁴,Walker Josephine¹,Vickerman Peter¹^ORCID

Affiliation:

1. Population Health Sciences, Bristol Medical School University of Bristol Bristol UK

2. Médecins Sans Frontières (MSF) Nairobi Kenya

3. Médecins du Monde (MdM) Nairobi Kenya

4. National AIDS and STI Control Programme (NASCOP) Nairobi Kenya

5. Kenya Aids NGO Consortium (KANCO) Nairobi Kenya

6. Ministry of Health—Republic of Kenya Nairobi Kenya

7. Yale University New Haven CT USA

8. Montefiore Medical Center/Albert Einstein College of Medicine New York NY USA

9. University of California ‐ San Francisco San Francisco CA USA

10. University of Manitoba Manitoba Canada

11. New York University New York USA